The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported cerebrovascular accident (treatment with medication(s)) associated with the stroke was due to the septic embolization.The reported sepsis (treatment with medication(s)) and hemorrhage (treatment with medication(s)) associated with the septic embolization, the reported endocarditis (treatment with medication(s)) associated with the vegetation on the clip, and the reported mitral valve insufficiency/ regurgitation (recurrent mr), were due to the infection.The reported infection (treatment with medication(s)) appears to be due to the radial arterial cannula.The reported patient effects of endocarditis, mitral regurgitation, cerebrovascular accident, hemorrhage, infection, and sepsis, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported medication required and hospitalization were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
This is filed to report an infection, recurrent mitral regurgitation, hemorrhagic stroke, sepsis and intervention.It was reported that on (b)(6) 2022, a mitraclip procedure was performed to treat grade 4 functional mitral regurgitation (mr).One clip was implanted with no reported issue.Signs of infection presented during the hospital stay.The source of infection was thought to be from the radial arterial cannula.A large vegetation on the mitraclip and severe mr was observed.Transient improvement was noted, but then progressive decline with antibiotic treatment.The patient was ischemic, then suffered a hemorrhagic stroke due to a septic embolism.The patient was in poor condition, mechanically ventilated, and remained septic.No additional information was provided.
|